APO RESEARCH · REPORT
Botulinum Toxin A
Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
Product & engineering
Understand the product.
Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
Selected research
Industry Research
Botulinum Toxin A Industry Research Report 2026
Market perspective
Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
Read the full market overview
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
Report Scope
This report quantifies the global Botulinum Toxin A market in terms of revenue (US$ million) and, where applicable, service volume (Kilo Bottles), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Kilo Bottles) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Botulinum Toxin A.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Botulinum Toxin A Market by Company
Allergan (AGN)
Ipsen
Merz Pharmaceuticals
Medytox
BTXA
Botulinum Toxin A Segment by Type
50iu
100iu
Other
Botulinum Toxin A Segment by Application
Medical Use
Beauty Use
Botulinum Toxin A Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botulinum Toxin A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Botulinum Toxin A and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botulinum Toxin A.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Botulinum Toxin A companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50iu
- 100iu
- Other
Applications
- Medical Use
- Beauty Use
Companies covered
- Allergan (AGN)
- Ipsen
- Merz Pharmaceuticals
- Medytox
- BTXA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Botulinum Toxin A by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 50iu
- 2.2.3 100iu
- 2.2.4 Other
- 2.3 Botulinum Toxin A by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Use
- 2.3.3 Beauty Use
- 2.4 Assumptions and Limitations
3 Botulinum Toxin A Breakdown Data by Type
- 3.1 Global Botulinum Toxin A Historic Market Size by Type (2021-2026)
- 3.2 Global Botulinum Toxin A Forecasted Market Size by Type (2027-2032)
4 Botulinum Toxin A Breakdown Data by Application
- 4.1 Global Botulinum Toxin A Historic Market Size by Application (2021-2026)
- 4.2 Global Botulinum Toxin A Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Botulinum Toxin A Market Perspective (2021-2032)
- 5.2 Global Botulinum Toxin A Growth Trends by Region
- 5.2.1 Global Botulinum Toxin A Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Botulinum Toxin A Historic Market Size by Region (2021-2026)
- 5.2.3 Botulinum Toxin A Forecasted Market Size by Region (2027-2032)
- 5.3 Botulinum Toxin A Market Dynamics
- 5.3.1 Botulinum Toxin A Industry Trends
- 5.3.2 Botulinum Toxin A Market Drivers
- 5.3.3 Botulinum Toxin A Market Challenges
- 5.3.4 Botulinum Toxin A Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Botulinum Toxin A Players by Revenue
- 6.1.1 Global Top Botulinum Toxin A Players by Revenue (2021-2026)
- 6.1.2 Global Botulinum Toxin A Revenue Market Share by Players (2021-2026)
- 6.2 Global Botulinum Toxin A Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Botulinum Toxin A Head Office and Area Served
- 6.4 Global Botulinum Toxin A Players, Product Type & Application
- 6.5 Global Botulinum Toxin A Manufacturers Established Date
- 6.6 Global Botulinum Toxin A Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Botulinum Toxin A Market Size (2021-2032)
- 7.2 North America Botulinum Toxin A Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Botulinum Toxin A Market Size by Country (2021-2026)
- 7.4 North America Botulinum Toxin A Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Botulinum Toxin A Market Size (2021-2032)
- 8.2 Europe Botulinum Toxin A Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Botulinum Toxin A Market Size by Country (2021-2026)
- 8.4 Europe Botulinum Toxin A Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Botulinum Toxin A Market Size (2021-2032)
- 9.2 Asia-Pacific Botulinum Toxin A Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Botulinum Toxin A Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Botulinum Toxin A Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Botulinum Toxin A Market Size (2021-2032)
- 10.2 South America Botulinum Toxin A Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Botulinum Toxin A Market Size by Country (2021-2026)
- 10.4 South America Botulinum Toxin A Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Botulinum Toxin A Market Size (2021-2032)
- 11.2 Middle East & Africa Botulinum Toxin A Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Botulinum Toxin A Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Botulinum Toxin A Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Allergan (AGN)
- 12.1.1 Allergan (AGN) Company Information
- 12.1.2 Allergan (AGN) Business Overview
- 12.1.3 Allergan (AGN) Revenue in Botulinum Toxin A Business (2021-2026)
- 12.1.4 Allergan (AGN) Botulinum Toxin A Product Portfolio
- 12.1.5 Allergan (AGN) Recent Developments
- 12.2 Ipsen
- 12.2.1 Ipsen Company Information
- 12.2.2 Ipsen Business Overview
- 12.2.3 Ipsen Revenue in Botulinum Toxin A Business (2021-2026)
- 12.2.4 Ipsen Botulinum Toxin A Product Portfolio
- 12.2.5 Ipsen Recent Developments
- 12.3 Merz Pharmaceuticals
- 12.3.1 Merz Pharmaceuticals Company Information
- 12.3.2 Merz Pharmaceuticals Business Overview
- 12.3.3 Merz Pharmaceuticals Revenue in Botulinum Toxin A Business (2021-2026)
- 12.3.4 Merz Pharmaceuticals Botulinum Toxin A Product Portfolio
- 12.3.5 Merz Pharmaceuticals Recent Developments
- 12.4 Medytox
- 12.4.1 Medytox Company Information
- 12.4.2 Medytox Business Overview
- 12.4.3 Medytox Revenue in Botulinum Toxin A Business (2021-2026)
- 12.4.4 Medytox Botulinum Toxin A Product Portfolio
- 12.4.5 Medytox Recent Developments
- 12.5 BTXA
- 12.5.1 BTXA Company Information
- 12.5.2 BTXA Business Overview
- 12.5.3 BTXA Revenue in Botulinum Toxin A Business (2021-2026)
- 12.5.4 BTXA Botulinum Toxin A Product Portfolio
- 12.5.5 BTXA Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst